ABSTRACT
the forebrains of neonatal mice, the rearranged loxP locus from recombination could be detected in the injected regions for at least 8 weeks. Taken together, these results demonstrate that the Adv/cre vector expressing a functional cre protein is capable of mediating loxP-dependent recombination in various tissues and the recombined gene locus may in some cases be maintained for an extended period. The use of the adenovirus vector expressing cre combined with localized delivery to specific tissues may provide an efficient means to achieve conditional gene expression or knockout with precise spatiotemporal control.
The analysis of gene function in vivo requires the ability to manipulate genes in a precise spatiotemporal manner. Current methods use germ-line transgenic techniques in which a foreign gene is introduced or an endogenous gene is deleted in the host genome throughout the life of the organism (1, 2) . The phenotypes that result from the gain or loss of function have provided insights into the physiological functions of particular genes in development and disease (3) . For genes that are expressed in multiple areas and times during development and in the adult (for example, see ref. 4) , the analysis of their function would be facilitated by the ability to alter gene expression at restricted times and in highly localized areas. One approach to achieve such conditional gene manipulation is the use of the newly developed cre-loxP system in transgenic animals (5, 6) .
Cre is a 38-kDa DNA recombinase that is both necessary and sufficient for sequence-specific recombination in bacteriophage P1. The recombination occurs between two loxP
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sequences, each of which is 34 bp in length (7, 8) . The intramolecular recombination of two loxP sites (oriented either head-to-head or head-to-tail) results in an inversion or deletion of the intervening DNA sequences, and an intermolecular recombination causes integration or reciprocal translocation at the loxP site. The cre-loxP system has been tested in various eukaryotic organisms and shown to function efficiently in mammalian cells (9) (10) (11) (12) (13) . It has been used in transgenic animals to achieve conditional gene activation or deletion (knockout) of targeted genes in specific tissues (5, 6, 14) . Generally, the system requires cross-breeding of two (17) (18) (19) . After injection of the virus into tissues, the high levels of infectivity and the limited spread of the virus results in a localized expression pattern of the transgene in various somatic tissues, including the brain, liver, lung, heart, and muscle (17) (18) (19) (21) . The presence of the cytomegalovirus promoter rather than the HSV promoter was not expected to lead to major differences in infectivity or expression. Both viruses were prepared as described (21) . Titers Analysis of the Transgenic Animals. After administration of adenovirus as described above, the treated animals were killed and genomic DNA from various tissues was extracted (QiAmp Tissue Kit; Qiagen, Chatsworth, CA) and analyzed for the presence of recombination products by PCR as described (5) . For Southern blot analysis of the loxP locus, the genomic DNA from the mouse tissues was digested with EcoRI and HindIII and blotted with the 1652-bp 32P-labeled EcoRI to HindIII fragment from the pBS241 plasmid (5) containing the Stop sequences. For reverse transcriptase-PCR analysis of the cre mRNA, total RNA was isolated from mouse tissues (Qiagen). The first strand cDNA was synthesized using avian myeloblastosis virus reverse transcriptase (Boehringer Mannheim) in the presence of oligo-dT primers followed by PCR amplification using primers specific for cre coding sequences as described (5) . All experiments were performed on a minimum of three animals and the PCR analyses were repeated a minimum of three times.
Histochemical Analysis. Adult mice infused with Adv/3-gal that were to be used for histochemical analysis (n = 6) were perfused, and the tissue was removed, sectioned, and stained for 3-gal activity as previously described (22 homozygous maA-Stop-Tag transgene (hereafter referred to as loxP mice) as our in vivo system (5) . Approximately 1010 pfu of the Adv/cre or Adv/,3-gal were infused into adult loxP mice by tail vein injection. Five days after the injection of the adenovirus vector, the livers and brains of the animals were collected and genomic DNA and total RNA were prepared from these tissues as described in Materials and Methods. The RNA samples were subjected to reverse transcription and amplification of first-strand cDNA by PCR using primers specific for the cre coding sequences (5) . Genomic DNA samples were analyzed by PCR using primers outside of the two loxP sequences. The PCR analysis should yield a 1536-bp product from the intact loxP locus in the transgene or give a 220-bp product as the result of cre-induced recombination between the two loxP sites and the subsequent deletion of the 1.3-kb Stop sequences (5; see Fig. 1 ).
After intravenous injections of Adv/cre, cre mRNA was detected by reverse transcriptase (RT)-PCR in the liver (Fig.  2A, lane 6) but not in the brain (Fig. 2A, lane 5) . This was consistent with previous studies using other adenoviruses injected through the tail vein (23 expression in either tissue ( Fig. 2A, lanes 7 and 8) . PCR examination of genomic DNA using specific primers for the loxP locus produced a 220-bp PCR product only in the livers of the Adv/cre-treated animals ( Fig. 2A, lane 2) but not in the brains (Fig. 2A, lane 1) . In control animals injected intravenously with the Adv/P3-gal vector, the 1536-bp PCR product from the intact loxP transgene (but not the 220-bp fragment) was detected in both the liver and the brain ( Fig. 2A, lanes 3  and 4) . The identities of these PCR products were confirmed by restriction enzyme analysis (data not shown). Southern blot analysis was performed to assess the efficiency of the Adv/cre-mediated recombination at the loxP locus. The intact loxP site in the transgene was detected as a prominent 1764-bp hybridization signal in DNA samples from the brain of the Adv/cre-treated mice or from the brain or the liver of the Adv/3-gal-treated control animals (Fig. 2B, lanes B, BO, and LO respectively). However, the hybridization signal was markedly reduced in the liver of the Adv/cre-treated animals (Fig. 2B, lane L) . Instead, a low molecular weight smear was observed representing heterogeneous extrachromosomal recombination products resulting from the random pairing between any of the loxP sites in the approximately 50 tandomly repeated copies of the transgene (5; J. G. Pichel, personal communication). The extent of the recombination at the loxP locus measured by the reduction of the 1764-bp signal was estimated to be >99% in the liver (Fig. 2B, lane L) .
cre mRNA expression as detected by RT-PCR correlated with the recombination events as detected by PCR analysis and quantitated by Southern blot analysis in the Adv/cre-treated animals. These results suggested that the Adv/cre vector produced a functional cre gene protein capable of mediating efficient recombination between the loxP sites in vivo.
Recombination in Somatic Tissues After Different Routes of Adv/cre Administration. We examined loxP-specific recombination in different organs 5 days after intravenous or intracerebral infusion of the Adv/cre vector. Genomic DNA was prepared from different tissues, including liver, kidney, spleen, lung, heart, and brain, and the samples were analyzed by PCR for loxP-specific recombination. When the Adv/cre vector was delivered (1010 pfu) via intravenous infusion, high levels of recombination were reproducibly detected in the liver (Fig. 3 , lane 1) and spleen (lane 3). Lower levels were seen in the kidney (lane 2), heart (lane 4), and lung (lane 5). Only trace levels of recombination were found in the brain (lane 6) , presumably because the brain-blood barrier blocked the viral particles from reaching and infecting brain tissues (24) . Control animals injected with Adv/f3-gal showed no cre-mediated recombination (Fig. 3, lanes C1-C6) .
To demonstrate recombination mediated by Adv/cre in the brain, -1.5 x 108 pfu was stereotaxically infused into the --Now cerebral cortex, hippocampus, and cerebellum on one side. Five days after the infusion, the brain tissues were dissected and genomic DNA was isolated for PCR analysis. loxPdependent recombination was evident in the injected brain regions (Fig. 3B, lanes 1, 3, and 5 ) and was either detected at lower levels or not detectable in corresponding regions of the contralateral side (Fig. 3B, lanes 2, 4, and 6 ). Some recombination was also observed in the liver and kidney (lanes 7 and 8, respectively), presumably due to leakage of the virus into the circulatory system.
To examine the distribution of virally infected cells within different tissues, the Adv/,B-gal vector was used. Histochemical analysis for 1-galactosidase in mice that received the Adv/03-gal virus (1010 pfu) intravenously revealed numerous positively stained cells throughout the liver (Fig. 4A) . In the kidney, 83-gal staining was seen in the tubular epithelial cells of the cortex (Fig. 4B ) but was absent in the medulla (data not shown). In the spleen, cells outside of the germinal zone were positively stained for (3-gal (Fig. 4C) . (3-Gal positive cells were seen throughout the lung and heart (Fig. 4 D and E) but at a lower density as compared to the liver, spleen, and kidney. Only a very few cells were positive for (3-gal in the brain; many of these had the appearance of perivascular microglia (Fig. 4F) . When Adv/f3-gal vector (2.2 x 108 pfu) was injected intracerebrally, numerous virally infected cells were observed at the injection sites (Fig. 4 G and H) and some weakly stained cells could be detected in other brain areas (data not shown) presumably because of retrograde transport of the viral particles by axons projecting to the injection areas (25, 26) . In addition, some ,3-gal positive cells were seen in the liver and kidney (data not shown) presumably due to leakage of the viral particles into circulation during the procedure. The distribution patterns of Adv/03-gal were in good agreement with previous reports (23) and were qualitatively correlated with the observed distribution of recombination events after intravenous and intracerebral injection of Adv/cre. These results demonstrate that using different delivery routes, Adv/cre virus could induce loxP-dependent recombination in different tissues including the liver, spleen, and specified local regions of the brain.
Long-Term Stability of Recombination at loxP Site in Neonatal Mouse Brains. The ability to induce and maintain gene rearrangement would be important for the analysis of phenotypic changes over a sustained periods of time during development. We therefore examined whether loxP-dependent recombination could be achieved and recombination products could be maintained throughout neonatal brain development. Adv/cre (0.3 ,ul, -1.0 x 108 pfu) was injected into one hemisphere of newborn loxP mice. Two to 8 weeks after injection, genomic DNA was isolated from each hemisphere and subjected to PCR analysis. loxP-dependent recombination products were detected in the injected hemispheres at all the time points during the entire experimental period (Fig. 5) . Lower levels of recombination products were also occasionally seen in the contralateral hemisphere, presumably due to retrograde transport (see Fig. 5, lanes 8, 10, and 12 , for examples). These results demonstrate that the Adv/cre vector can induce loxP-dependent recombination in the neonatal brain and suggest that a mosaic of the loxP transgene may be established and maintained in selected regions of the developing nervous system.
DISCUSSION
We have found that a replication-defective adenovirus expressing cre recombinase is capable of mediating efficient loxP-dependent recombination in vivo. This extends previous work, which has shown that adenovirus vectors expressing the cre protein can mediate loxP-dependent DNA recombination in tissue culture cells (27) . After systemic delivery, the cre adenoviral vector was able to induce recombination in a broad range of nonneural tissues, including the liver, spleen, and kidney. Other tissues, such as brain and heart, had low levels of recombination at the loxP sites. However, injections of Adv/cre directly into adult brains produced loxP-specified recombination in targeted regions. Adv/cre injections into neonatal brains resulted in loxP-dependent recombination and the rearranged loxP locus was stable in the genome for at least 8 weeks. These experiments indicate that site-specific recom- 
